Passage Bio Reports Updated Interim Data from upliFT-D Trial and Provides Regulatory and Corporate Updates

Go back to Passage Bio Reports Updated Interim Data from upliFT-D Trial and Provides Regulatory and Corporate Updates
(NASDAQ: PASG) Delayed: 4.46 --0 (-0%)
Previous Close $4.46    52 Week High
Open $4.46    52 Week Low
Day High $4.46    P/E N/A 
Day Low $4.46    EPS
Volume      

(NASDAQ: PASG) Delayed: 4.46 --0 (-0%)
Previous Close $4.46    52 Week High
Open $4.46    52 Week Low
Day High $4.46    P/E N/A 
Day Low $4.46    EPS
Volume